LQDA
LQDA
NASDAQ · Pharmaceuticals

Liquidia Corp

$47.86
+3.46 (+7.79%)
Analyst Consensus
Buy
15
Analysts
High
Coverage
Buy 11 73%
Hold 4 27%
Sell 0 0%
Price Target
Analyst Price Target -9.8% upside
Low Target $30.71
Average Target $43.17
High Target $51.56
Current Price $47.86
Current
$47.86
Target
$43.17
$30.71 $43.17 avg $51.56
Scenario Analysis
Bear Case
$30.71
-35.8%
Low target
Base Case
$43.17
-9.8%
Avg target
Bull Case
$51.56
+7.7%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$93.61
-48.9% from high
52-Week Low
$22.31
+114.5% from low
50-Day SMA
$49.99
-4.3% vs SMA
200-Day SMA
$54.45
-12.1% vs SMA
RSI (14)
72.7
Overbought
Target vs 52W High
$43.17
-53.9% vs high
Next Earnings Report
Nov 10, 2026 · Before Market Open
Today
EPS Est: $0.98
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -6.5%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +6.2%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.9%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -47.3%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +156.1%